Shoulder Innovations (SI) Competitors

$13.56 +0.19 (+1.44%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$14.12 +0.56 (+4.11%)

As of 04:00 AM Eastern

SI vs. COIN, BVS, INMD, SSII, and SGP

Should you buy Shoulder Innovations stock or one of its competitors? MarketBeat compares Shoulder Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Shoulder Innovations include Coinbase Global (COIN), Bioventus (BVS), InMode (INMD), SS Innovations International (SSII), and Spyglass Pharma (SGP).

How does Shoulder Innovations compare to Coinbase Global?

Coinbase Global (NASDAQ:COIN) and Shoulder Innovations (NYSE:SI) are related companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends.

Coinbase Global has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Coinbase Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Coinbase Global	$7.18B	7.42	$1.26B	$2.66	75.86
Shoulder Innovations	$47.32M	5.94	-$40.36M	-$218.68	N/A

In the previous week, Coinbase Global had 118 more articles in the media than Shoulder Innovations. MarketBeat recorded 123 mentions for Coinbase Global and 5 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.21 beat Shoulder Innovations' score of 0.00 indicating that Coinbase Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Coinbase Global	36 Very Positive mention(s)	14 Positive mention(s)	16 Neutral mention(s)	35 Negative mention(s)	9 Very Negative mention(s)	Neutral
Shoulder Innovations	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Coinbase Global has a net margin of 12.20% compared to Shoulder Innovations' net margin of -85.29%. Coinbase Global's return on equity of 4.06% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Coinbase Global	12.20%	4.06%	2.05%
Shoulder Innovations	-85.29%	-37.68%	-18.63%

Coinbase Global presently has a consensus price target of $251.91, indicating a potential upside of 24.83%. Shoulder Innovations has a consensus price target of $21.00, indicating a potential upside of 54.84%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, analysts plainly believe Shoulder Innovations is more favorable than Coinbase Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Coinbase Global	4 Sell rating(s)	10 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.45
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

68.8% of Coinbase Global shares are owned by institutional investors. 16.7% of Coinbase Global shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Coinbase Global beats Shoulder Innovations on 12 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to Bioventus?

Shoulder Innovations (NYSE:SI) and Bioventus (NASDAQ:BVS) are both small-cap surgical, medical, and dental instruments and supplies industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Bioventus has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	5.94	-$40.36M	-$218.68	N/A
Bioventus	$576.30M	1.50	$22.73M	$0.41	25.37

In the previous week, Shoulder Innovations had 3 more articles in the media than Bioventus. MarketBeat recorded 5 mentions for Shoulder Innovations and 2 mentions for Bioventus. Bioventus' average media sentiment score of 0.72 beat Shoulder Innovations' score of 0.00 indicating that Bioventus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bioventus	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bioventus has a net margin of 4.94% compared to Shoulder Innovations' net margin of -85.29%. Bioventus' return on equity of 29.97% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-85.29%	-37.68%	-18.63%
Bioventus	4.94%	29.97%	9.52%

Shoulder Innovations currently has a consensus price target of $21.00, suggesting a potential upside of 54.84%. Bioventus has a consensus price target of $14.00, suggesting a potential upside of 34.62%. Given Shoulder Innovations' higher probable upside, research analysts plainly believe Shoulder Innovations is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

62.9% of Bioventus shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by insiders. Comparatively, 33.0% of Bioventus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Bioventus beats Shoulder Innovations on 12 of the 16 factors compared between the two stocks.

How does Shoulder Innovations compare to InMode?

Shoulder Innovations (NYSE:SI) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Shoulder Innovations currently has a consensus price target of $21.00, suggesting a potential upside of 54.84%. InMode has a consensus price target of $16.00, suggesting a potential upside of 13.96%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, research analysts plainly believe Shoulder Innovations is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

68.0% of InMode shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

InMode has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	5.94	-$40.36M	-$218.68	N/A
InMode	$370.49M	2.40	$93.83M	$1.36	10.32

In the previous week, InMode had 4 more articles in the media than Shoulder Innovations. MarketBeat recorded 9 mentions for InMode and 5 mentions for Shoulder Innovations. InMode's average media sentiment score of 0.36 beat Shoulder Innovations' score of 0.00 indicating that InMode is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InMode has a net margin of 23.27% compared to Shoulder Innovations' net margin of -85.29%. InMode's return on equity of 13.47% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-85.29%	-37.68%	-18.63%
InMode	23.27%	13.47%	11.95%

Summary

InMode beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to SS Innovations International?

Shoulder Innovations (NYSE:SI) and SS Innovations International (NASDAQ:SSII) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Shoulder Innovations presently has a consensus price target of $21.00, suggesting a potential upside of 54.84%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, research analysts plainly believe Shoulder Innovations is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Shoulder Innovations and Shoulder Innovations both had 5 articles in the media. SS Innovations International's average media sentiment score of 0.28 beat Shoulder Innovations' score of 0.00 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SS Innovations International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

SS Innovations International has a net margin of -28.54% compared to Shoulder Innovations' net margin of -85.29%. SS Innovations International's return on equity of -30.23% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-85.29%	-37.68%	-18.63%
SS Innovations International	-28.54%	-30.23%	-17.50%

SS Innovations International has lower revenue, but higher earnings than Shoulder Innovations. SS Innovations International is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	5.94	-$40.36M	-$218.68	N/A
SS Innovations International	$42.49M	18.79	-$12.13M	-$0.06	N/A

Summary

SS Innovations International beats Shoulder Innovations on 7 of the 12 factors compared between the two stocks.

How does Shoulder Innovations compare to Spyglass Pharma?

Shoulder Innovations (NYSE:SI) and Spyglass Pharma (NASDAQ:SGP) are both small-cap surgical, medical, and dental instruments and supplies industry companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Shoulder Innovations presently has a consensus price target of $21.00, suggesting a potential upside of 54.84%. Spyglass Pharma has a consensus price target of $45.00, suggesting a potential upside of 88.92%. Given Spyglass Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Spyglass Pharma is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Spyglass Pharma	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Shoulder Innovations had 4 more articles in the media than Spyglass Pharma. MarketBeat recorded 5 mentions for Shoulder Innovations and 1 mentions for Spyglass Pharma. Spyglass Pharma's average media sentiment score of 1.87 beat Shoulder Innovations' score of 0.00 indicating that Spyglass Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Shoulder Innovations	Neutral
Spyglass Pharma	Very Positive

Spyglass Pharma has a net margin of 0.00% compared to Shoulder Innovations' net margin of -85.29%. Spyglass Pharma's return on equity of 0.00% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-85.29%	-37.68%	-18.63%
Spyglass Pharma	N/A	N/A	N/A

Spyglass Pharma has lower revenue, but higher earnings than Shoulder Innovations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	5.94	-$40.36M	-$218.68	N/A
Spyglass Pharma	N/A	N/A	N/A	N/A	N/A

Summary

Spyglass Pharma beats Shoulder Innovations on 6 of the 8 factors compared between the two stocks.

Get Shoulder Innovations News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SI vs. The Competition

Export

Metric	Shoulder Innovations	Surgical, Medical, And Dental Instruments And Supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$277.13M	$3.33B	$6.30B	$22.96B
Dividend Yield	N/A	N/A	2.79%	4.06%
P/E Ratio	-0.06	3.17	21.03	28.29
Price / Sales	5.94	315.51	548.94	24.50
Price / Cash	N/A	4.11	42.94	25.11
Price / Book	1.99	3.92	9.84	4.73
Net Income	-$40.36M	-$76.79M	$3.55B	$1.07B
7 Day Performance	6.28%	-1.02%	-0.52%	-1.11%
1 Month Performance	-9.28%	0.75%	1.21%	1.36%
1 Year Performance	N/A	95.33%	41.24%	24.41%

Shoulder Innovations Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SI Shoulder Innovations	3.1394 of 5 stars	$13.56 +1.4%	$21.00 +54.8%	N/A	$277.13M	$47.32M	N/A	61	News Coverage Earnings Report
COIN Coinbase Global	4.0939 of 5 stars	$201.16 +4.2%	$250.04 +24.3%	-21.4%	$50.96B	$6.56B	75.62	4,951	Trending News Earnings Report Analyst Downgrade Analyst Revision
BVS Bioventus	4.3214 of 5 stars	$10.50 -1.4%	$14.00 +33.3%	N/A	$885.60M	$568.09M	25.61	1,200	Gap Up
INMD InMode	1.7083 of 5 stars	$13.96 +0.3%	$16.00 +14.6%	-5.9%	$881.95M	$370.49M	10.26	480
SSII SS Innovations International	1.35 of 5 stars	$3.87 -1.5%	N/A	-60.7%	$786.52M	$42.49M	N/A	4	Earnings Report Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SI) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shoulder Innovations (SI) Competitors

SI vs. COIN, BVS, INMD, SSII, and SGP

How does Shoulder Innovations compare to Coinbase Global?

Summary

How does Shoulder Innovations compare to Bioventus?

Summary

How does Shoulder Innovations compare to InMode?

Summary

How does Shoulder Innovations compare to SS Innovations International?

Summary

How does Shoulder Innovations compare to Spyglass Pharma?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shoulder Innovations (SI) Competitors

SI vs. COIN, BVS, INMD, SSII, and SGP

How does Shoulder Innovations compare to Coinbase Global?

Which has higher valuation & earnings, COIN or SI?

Does the media prefer COIN or SI?

Is COIN or SI more profitable?

Do analysts recommend COIN or SI?

Do institutionals and insiders have more ownership in COIN or SI?

Summary

How does Shoulder Innovations compare to Bioventus?

Which has better earnings and valuation, SI or BVS?

Does the media prefer SI or BVS?

Is SI or BVS more profitable?

Do analysts rate SI or BVS?

Do insiders & institutionals have more ownership in SI or BVS?

Summary

How does Shoulder Innovations compare to InMode?

Do analysts rate SI or INMD?

Do insiders & institutionals have more ownership in SI or INMD?

Which has better earnings and valuation, SI or INMD?

Does the media prefer SI or INMD?

Is SI or INMD more profitable?

Summary

How does Shoulder Innovations compare to SS Innovations International?

Do analysts prefer SI or SSII?

Does the media refer more to SI or SSII?

Is SI or SSII more profitable?

Which has higher earnings & valuation, SI or SSII?

Summary

How does Shoulder Innovations compare to Spyglass Pharma?

Do analysts prefer SI or SGP?

Does the media refer more to SI or SGP?

Is SI or SGP more profitable?

Which has higher earnings & valuation, SI or SGP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools